Published in World J Gastroenterol on February 28, 2014
Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut (2014) 0.94
Understanding the colon cancer stem cells and perspectives on treatment. Cancer Cell Int (2015) 0.86
Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer. Front Oncol (2015) 0.83
Heterogeneity of the level of activity of lgr5+ intestinal stem cells. Int J Mol Cell Med (2014) 0.76
Isolation and characterization of putative mesenchymal stem cells from mammalian gut. Cytotechnology (2016) 0.75
IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer. Oncotarget (2016) 0.75
Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment. Stem Cells Int (2016) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature (2009) 19.18
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell (2002) 13.92
Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58
Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell (2009) 12.96
Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell (2010) 12.23
Crypt stem cells as the cells-of-origin of intestinal cancer. Nature (2008) 11.66
Linking colorectal cancer to Wnt signaling. Cell (2000) 11.58
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep (2008) 10.71
Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature (2010) 10.60
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet (1998) 10.51
Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet (2008) 10.22
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem (2008) 10.08
Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med (2009) 10.01
Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer (2005) 9.04
Applying the principles of stem-cell biology to cancer. Nat Rev Cancer (2003) 8.95
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol (2008) 8.72
Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat (1974) 8.05
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol (2010) 7.73
Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science (2012) 6.55
Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev (2003) 6.27
A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature (2011) 5.45
Micrometastases and survival in stage II colorectal cancer. N Engl J Med (1998) 5.11
Cancer stem cells: current status and evolving complexities. Cell Stem Cell (2012) 5.07
Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature (2013) 4.83
Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet (2006) 4.82
Intestinal stem cell replacement follows a pattern of neutral drift. Science (2010) 4.62
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A (2008) 4.60
Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell (2012) 4.58
Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell (2008) 4.43
Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer (2008) 4.30
The intestinal stem cell. Genes Dev (2008) 4.21
The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci U S A (2011) 3.80
Clonal analysis of human colorectal tumors. Science (1987) 3.72
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J (2012) 3.70
Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell (2005) 3.67
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res (2006) 3.65
The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol (1997) 3.32
Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol (2012) 3.30
Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol (2011) 3.21
Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature (1977) 2.82
Cancer stem cells: the challenges ahead. Nat Cell Biol (2013) 2.78
The gastrointestinal tract stem cell niche. Stem Cell Rev (2006) 2.73
Colon cancer stem cells: promise of targeted therapy. Gastroenterology (2010) 2.58
Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology (2012) 2.57
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut (2012) 2.40
Understanding cancer stem cell heterogeneity and plasticity. Cell Res (2012) 2.39
Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol (2013) 2.35
Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet (2012) 2.33
Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J Cell Biol (2011) 2.21
Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology (2010) 2.10
Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes. EMBO J (2011) 2.08
EMT is the dominant program in human colon cancer. BMC Med Genomics (2011) 2.05
Continuous labelling studies on mouse skin and intestine. Cell Tissue Kinet (1974) 1.97
Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively. Stem Cells (2009) 1.89
Identifying the stem cell of the intestinal crypt: strategies and pitfalls. Cell Stem Cell (2012) 1.88
Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract. Gastroenterology (2010) 1.86
DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization. J Neurosci (2000) 1.77
Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status. J Cell Sci (1999) 1.75
The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol (2012) 1.65
Reprogramming somatic cells towards pluripotency by defined factors. Curr Opin Biotechnol (2007) 1.65
Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg (2000) 1.59
Intact function of Lgr5 receptor-expressing intestinal stem cells in the absence of Paneth cells. Proc Natl Acad Sci U S A (2012) 1.58
Paneth cells in intestinal homeostasis and tissue injury. PLoS One (2012) 1.57
Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells (2012) 1.55
Biologic challenges in the detection of circulating tumor cells. Cancer Res (2012) 1.55
Colon cancer stem cells. J Mol Med (Berl) (2009) 1.53
Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism. Gastroenterology (2009) 1.53
Colorectal cancer stem cells. Stem Cells (2012) 1.47
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism. J Nanobiotechnology (2011) 1.39
Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med (2012) 1.35
STUDIES ON THE MORPHOGENESIS OF ADENOMATOUS POLYPS IN THE HUMAN COLON. Cancer (1963) 1.32
Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. Gastroenterology (2012) 1.32
Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol Ther (2007) 1.26
Delta1 expression, cell cycle exit, and commitment to a specific secretory fate coincide within a few hours in the mouse intestinal stem cell system. PLoS One (2011) 1.24
Lgr proteins in epithelial stem cell biology. Development (2013) 1.20
Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med (1995) 1.20
Origin of the brush cell lineage in the mouse intestinal epithelium. Dev Biol (2011) 1.09
A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway. J Biol Chem (2012) 1.07
Wnt signaling and colon tumorigenesis--a view from the periphery. Exp Cell Res (2011) 1.06
Notch: architect, landscaper, and guardian of the intestine. Gastroenterology (2011) 1.03
Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cells. J Cell Biochem (2011) 1.03
Role of Notch signaling in colon homeostasis and carcinogenesis. Cancer Sci (2011) 1.02
Biology and significance of circulating and disseminated tumour cells in colorectal cancer. Langenbecks Arch Surg (2012) 1.01
Alternative splice variants of doublecortin-like kinase are differentially expressed and have different kinase activities. J Biol Chem (2002) 0.92
Epithelial-mesenchymal transition associates with maintenance of stemness in spheroid-derived stem-like colon cancer cells. PLoS One (2013) 0.91
BMI-1: a protein expressed in stem cells, specialized cells and tumors of the gastrointestinal tract. Histol Histopathol (2006) 0.86
Investigation of doublecortin and calcium/calmodulin-dependent protein kinase-like-1-expressing cells in the mouse stomach. J Gastroenterol Hepatol (2010) 0.82